» Articles » PMID: 4672507

Immunochemical Studies on Human Calcitonin M Leading to Information on the Shape of the Molecule

Overview
Journal Biochem J
Specialty Biochemistry
Date 1972 Mar 1
PMID 4672507
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

1. Two antisera were obtained from a single rabbit. Both are highly specific for human calcitonin M but react with different parts of the amino acid sequence. 2. The different sequences that react with the antibodies of the two antisera were located. The first antiserum reacts at two sites in the molecule, one in the sequence residues 11-18, probably with residue 17 as the immunodominant group, and another on either side of the 28-29 peptide bond. The second antiserum, harvested 9 months later, reacts principally at one site bridging the 28-29 peptide bond. 3. A consideration of the properties of the hormone's binding sites and of data relating biological activity to structure enables some conclusions to be drawn with regard to the shape of the molecule. It appears that the peptide chain is folded to bring N- and C-termini closer together and that there is non-covalent interaction between regions in the chain near both termini. One of these is located near residue 8.

Citing Articles

Purification and partial characterization of high-molecular-weight forms of ectopic calcitonin from a human bronchial carcinoma cell line.

Lumsden J, Ham J, ELLISON M Biochem J. 1980; 191(1):239-46.

PMID: 6258582 PMC: 1162203. DOI: 10.1042/bj1910239.


Peptides from the calcitonin genes: molecular genetics, structure and function.

Breimer L, MacIntyre I, Zaidi M Biochem J. 1988; 255(2):377-90.

PMID: 3060108 PMC: 1135239. DOI: 10.1042/bj2550377.


[Structure-activity relationship of human calcitonin. III. Biological activity of synthetic analogues with shortened or terminally modified peptide chains (author's transl)].

Rittel W, Maier R, Brugger M, Kamber B, RINIKER B, Sieber P Experientia. 1976; 32(2):246-8.

PMID: 1269626 DOI: 10.1007/BF01937791.


Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma.

Sizemore G, Hpeath 3rd H, Larson J J Clin Invest. 1975; 55(5):1111-8.

PMID: 47335 PMC: 301858. DOI: 10.1172/JCI108012.

References
1.
RINIKER B, Neher R, Maier R, KAHNT F, Byfield P, Gudmundsson T . [Human calcitonin. I. Isolation and characterization]. Helv Chim Acta. 1968; 51(7):1738-42. DOI: 10.1002/hlca.19680510731. View

2.
Spragg J, TALAMO R, Suzuki K, Appelbaum D, Austen K, Haber E . Structural requirements for binding of bradykinin to antibody. II. Studies with bradykinin fragments. Biochemistry. 1968; 7(11):4086-9. DOI: 10.1021/bi00851a042. View

3.
Lequin R, HACKENG W, SCHOPMAN W . A radioimmunoassay for porcine calcitonin. J Endocrinol. 1969; 44(2):283-4. DOI: 10.1677/joe.0.0440283. View

4.
Neher R, RINIKER B, Rittel W, Zuber H . [Human calcitonin. Structure of calcitonin M and D]. Helv Chim Acta. 1968; 51(8):1900-5. DOI: 10.1002/hlca.19680510811. View

5.
Goodman J . Immunochemical specificity: recent conceptual advances. Immunochemistry. 1969; 6(1):139-49. DOI: 10.1016/0019-2791(69)90185-2. View